Literature DB >> 19946707

Expression of X-linked inhibitor of apoptosis protein in human prostate cancer specimens with and without neo-adjuvant hormonal therapy.

Shin-ichi Watanabe1, Yasuyoshi Miyata, Shigeru Kanda, Takahisa Iwata, Tomayoshi Hayashi, Hiroshi Kanetake, Hideki Sakai.   

Abstract

PURPOSE: X-linked inhibitor of apoptosis (XIAP) has high affinity and strong inhibitory activity on apoptosis-related caspase-3. The relationships between expression of XIAP and cleaved caspase-3, and response to neo-adjuvant hormonal therapy (NHT) remain elusive. The aim was to investigate whether NHT influences with XIAP expression in prostate cancer patients. In addition, the relationship between XIAP expression and apoptosis in patients who did or did not receive NHT was also investigated.
METHODS: Eighty-three patients who had undergone radical prostatectomy were examined retrospectively and divided into NHT group (n = 40) and non-NHT group (n = 43). Immunohistochemistry was used to analyze the expressions of XIAP and cleaved caspase-3. The apoptotic cells reconfirmed the number of terminal deoxynucleotidyl transferase-mediated nick and labeling (TUNEL)-positive cells.
RESULTS: In the non-NHT group, the proportion of TUNEL-positive cells correlated with expression of cleaved caspase-3 (r = 0.592, P < 0.001), and the expression of XIAP correlated negatively with that of cleaved caspase-3 and TUNEL-positive cells (r = -0.464, P < 0.001 and r = 0.431, P = 0.002, respectively). The expression of cleaved caspase-3, but not that of XIAP, was higher in NHT group than non-NHT group (P = 0.017). In the NHT group, there was no significant correlation between XIAP expression and cleaved caspase-3 expression or the proportion of TUNEL-positive cells.
CONCLUSIONS: NHT did not influence XIAP expression. We speculate that the inhibition of XIAP expression may reinforce the apoptotic effect of NHT and improve the prognosis in patients with prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19946707     DOI: 10.1007/s00432-009-0718-x

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  30 in total

Review 1.  Apoptosis without caspases: an inefficient molecular guillotine?

Authors:  C Borner; L Monney
Journal:  Cell Death Differ       Date:  1999-06       Impact factor: 15.828

2.  Cellular changes in prostate cancer cells induced by intermittent androgen suppression.

Authors:  Sari Laitinen; Paula M Martikainen; Teuvo L J Tammela; Tapio Visakorpi
Journal:  Eur Urol       Date:  2006-11-28       Impact factor: 20.096

Review 3.  Prostate specific antigen only progression of prostate cancer.

Authors:  J W Moul
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

4.  Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects.

Authors:  M E Gleave; S L Goldenberg; J L Chin; J Warner; F Saad; L H Klotz; M Jewett; V Kassabian; M Chetner; C Dupont; S Van Rensselaer
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

5.  Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers.

Authors:  Maryla Krajewska; Hoguen Kim; Chul Kim; Haeyoun Kang; Kate Welsh; Shu-Ichi Matsuzawa; Michelle Tsukamoto; Ronald G Thomas; Nuria Assa-Munt; Zhe Piao; Koichi Suzuki; Manuel Perucho; Stan Krajewski; John C Reed
Journal:  Clin Cancer Res       Date:  2005-08-01       Impact factor: 12.531

6.  Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors.

Authors:  A G Uren; M Pakusch; C J Hawkins; K L Puls; D L Vaux
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo.

Authors:  Xinbin Gu; Xiaodong Song; Yongheng Dong; Hui Cai; Eric Walters; Renshu Zhang; Xiaowu Pang; Tianpei Xie; Yinhan Guo; Rajagopalan Sridhar; Joseph A Califano
Journal:  Clin Cancer Res       Date:  2008-03-15       Impact factor: 12.531

8.  Caspase-3 and -6 expression and activation are targeted by hormone action in the rat ventral prostate during the apoptotic cell death process.

Authors:  Asma Omezzine; Claire Mauduit; Eric Tabone; Naoufel Nabli; Ali Bouslama; Mohamed Benahmed
Journal:  Biol Reprod       Date:  2003-04-30       Impact factor: 4.285

9.  Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines.

Authors:  M S Floyd; M St John Floyd; S J Teahan; J M Fitzpatrick; R W G Watson
Journal:  Prostate Cancer Prostatic Dis       Date:  2008-05-13       Impact factor: 5.554

10.  Finasteride induces apoptosis via Bcl-2, Bcl-xL, Bax and caspase-3 proteins in LNCaP human prostate cancer cell line.

Authors:  Jesús M Golbano; Pilar Lóppez-Aparicio; María N Recio; Miguel A Pérez-Albarsanz
Journal:  Int J Oncol       Date:  2008-04       Impact factor: 5.650

View more
  7 in total

1.  Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo.

Authors:  Dong Xiao; Shivendra Vikram Singh
Journal:  Pharm Res       Date:  2010-02-25       Impact factor: 4.200

2.  Stromal expression of Fer suppresses tumor progression in renal cell carcinoma and is a predictor of survival.

Authors:  Kensuke Mitsunari; Yasuyoshi Miyata; Shin-Ichi Watanabe; Akihiro Asai; Takuji Yasuda; Shigeru Kanda; Hideki Sakai
Journal:  Oncol Lett       Date:  2016-12-12       Impact factor: 2.967

3.  High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma.

Authors:  Kojiro Ohba; Yasuyoshi Miyata; Tomohiro Matsuo; Akihiro Asai; Kensuke Mitsunari; Yohei Shida; Shigeru Kanda; Hideki Sakai
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

4.  Stage-specific embryonic antigen-4 is a histological marker reflecting the malignant behavior of prostate cancer.

Authors:  Yuichiro Nakamura; Yasuyoshi Miyata; Tomohiro Matsuo; Yohei Shida; Tomoaki Hakariya; Kojiro Ohba; Takenobu Taima; Akihiro Ito; Tetsuji Suda; Sen-Itiroh Hakomori; Seiichi Saito; Hideki Sakai
Journal:  Glycoconj J       Date:  2019-06-26       Impact factor: 2.916

5.  Oral administration of E-type prostanoid (EP) 1 receptor antagonist suppresses carcinogenesis and development of prostate cancer via upregulation of apoptosis in an animal model.

Authors:  Masahito Masato; Yasuyoshi Miyata; Hiroki Kurata; Hidenori Ito; Kensuke Mitsunari; Akihiro Asai; Yuichiro Nakamura; Kyohei Araki; Yuta Mukae; Tsuyoshi Matsuda; Junki Harada; Tomohiro Matsuo; Kojiro Ohba; Hideki Sakai
Journal:  Sci Rep       Date:  2021-10-13       Impact factor: 4.379

6.  The enigmatic roles of caspases in tumor development.

Authors:  Richard Jäger; Ralf M Zwacka
Journal:  Cancers (Basel)       Date:  2010-11-24       Impact factor: 6.639

7.  Identifying New Candidate Genes and Chemicals Related to Prostate Cancer Using a Hybrid Network and Shortest Path Approach.

Authors:  Fei Yuan; You Zhou; Meng Wang; Jing Yang; Kai Wu; Changhong Lu; Xiangyin Kong; Yu-Dong Cai
Journal:  Comput Math Methods Med       Date:  2015-10-04       Impact factor: 2.238

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.